Risk of esophageal adenocarcinoma in patients with Barrett’s esophagus using proton pump inhibitors: a systematic review with meta-analysis and sequential trial analysis

BACKGROUND: Proton pump inhibitors (PPIs) have been used to treat Barrett’s esophagus (BE), but there seems to be insufficient evidence that PPIs can prevent esophageal adenocarcinoma (EAC) and high grade dysplasia (HGD). This study aimed to evaluate the effects of PPIs in BE patients. METHODS: PubM...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Lunan, Cao, Zhongsheng, Zhang, Chenjing, Pan, Wensheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798809/
https://www.ncbi.nlm.nih.gov/pubmed/35116488
http://dx.doi.org/10.21037/tcr-20-3362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798809/
https://www.ncbi.nlm.nih.gov/pubmed/35116488
http://dx.doi.org/10.21037/tcr-20-3362

Ejemplares similares